Group One Trading’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-193
Closed -$35K 8143
2020
Q4
$27K Buy
+193
New +$31.3K ﹤0.01% 5357
2018
Q3
Sell
-136
Closed -$11K 5718
2018
Q2
$11K Hold
136
﹤0.01% 4599
2018
Q1
$12K Buy
136
+71
+109% +$10.6K ﹤0.01% 4270
2017
Q4
$48K Buy
+65
New +$25.1K ﹤0.01% 3755
2017
Q2
Sell
-16
Closed -$4.3K 5191
2017
Q1
$5K Sell
16
-58
-78% -$26.9K ﹤0.01% 4294
2016
Q4
$44K Buy
74
+14
+23% +$14.8K ﹤0.01% 3329
2016
Q3
$68K Buy
60
+13
+28% +$14K ﹤0.01% 3165
2016
Q2
$51K Sell
47
-35
-43% -$43.9K ﹤0.01% 3296
2016
Q1
$105K Buy
+82
New +$117K ﹤0.01% 2786
2015
Q4
Sell
-151
Closed -$232K 5186
2015
Q3
$167K Buy
151
+86
+132% +$99.6K ﹤0.01% 2653
2015
Q2
$65K Sell
65
-43
-40% -$46.4K ﹤0.01% 3379
2015
Q1
$110K Buy
108
+53
+96% +$175K ﹤0.01% 2843
2014
Q4
$184K Sell
55
-3
-5% -$9.2K ﹤0.01% 2371
2014
Q3
$168K Buy
+58
New +$192K ﹤0.01% 2520
2014
Q2
Sell
-59
Closed -$222K 5566
2014
Q1
$322K Buy
+59
New +$311K 0.01% 2031

Other funds holding NBSE

Group One Trading's NBSE Position: Q1 2021 in Review

Group One Trading sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2021, closing a stake of 193 shares — an estimated $35K sold.

Group One Trading first reported a position in NBSE in Q1 2014 and held it in 15 quarters. The position peaked at $322K in Q1 2014. 56 funds tracked by Wall St. Rank hold NBSE as of Q1 2021.

  • Group One Trading reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Group One Trading sold 193 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $35K.
  • Group One Trading first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2014 and held it in 15 quarters.
  • Group One Trading's NeuBase Therapeutics, Inc. Common Stock position peaked at $322K in Q1 2014.
  • 56 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Group One Trading's 13F filing for Q1 2021, filed 12 May 2021.